Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
35.9M
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
19.6M
-
Shares change
-
-1.04M
-
Total reported value, excl. options
-
$114M
-
Value change
-
-$68.5M
-
Number of buys
-
43
-
Number of sells
-
-40
-
Price
-
$5.79
Significant Holders of BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) as of Q4 2024
93 filings reported holding BIOA - BioAge Labs, Inc. - Common Stock, par value $0.00001 per share as of Q4 2024.
BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.6M shares
of 35.9M outstanding shares and own 54.75% of the company stock.
Largest 10 shareholders include AH Capital Management, L.L.C. (3.23M shares), Cormorant Asset Management, LP (2.63M shares), Sofinnova Investments, Inc. (2.3M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (1.45M shares), TANG CAPITAL MANAGEMENT LLC (1.32M shares), RA CAPITAL MANAGEMENT, L.P. (1.31M shares), ORBIMED ADVISORS LLC (922K shares), RTW INVESTMENTS, LP (786K shares), Sands Capital Ventures, LLC (786K shares), and BlackRock, Inc. (712K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.